Effect of ultrasonic oscillation in combination with laser microsurgery on chronic periapical periodontitis
15 ago 2024
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Original Study
Pubblicato online: 15 ago 2024
Pagine: 66 - 73
Ricevuto: 27 dic 2023
Accettato: 01 lug 2024
DOI: https://doi.org/10.2478/ahem-2024-0008
Parole chiave
© 2024 Hongling Si et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
General data (n, x̄± s)
Control | 45 | 26.28±4.27 | 1.18±0.31 | 26/19 | 15/21/9 | 13/6/26 |
Treatment | 45 | 25.91±4.30 | 1.20±0.33 | 24/21 | 12/23/10 | 14/8/23 |
0.410 | 0.296 | 0.180 | 0.477 | 0.506 | ||
P | 0.683 | 0.768 | 0.671 | 0.788 | 0.776 |
O-PAI at different time points (x̄±s)
Control | 45 | 3.38±0.08 | 2.42±0.12 | 1.49±0.15 |
141.58, <0.001 | ||||
Before vs. 4 weeks after treatment: 7.44, <0.001 | ||||
Before vs. 8 weeks after treatment: 12.60, <0.001 | ||||
4 vs. 8 weeks after treatment: 6.14, <0.001 | ||||
Treatment | 45 | 3.41±0.09 | 2.37±0.11 | 1.26±0.10 |
254.04, <0.001 | ||||
Before vs. 4 weeks after treatment: 8.38, <0.001 | ||||
Before vs. 8 weeks after treatment: 17.29, <0.001 | ||||
4 vs. 8 weeks after treatment: 9.38, <0.001 | ||||
0.284 | 3.346 | 5.144 | ||
Pbetween groups | 0.777 | <0.001 | <0.001 |
Serum biochemical indicators of bone formation (x̄± s)
Control | 45 | 2.54±0.41 | 1.98±0.14 | 120.31±8.92 |
Treatment | 45 | 3.20±0.53 | 2.35±0.23 | 150.94±10.83 |
6.607 | 9.218 | 14.645 | ||
P | <0.001 | <0.001 | <0.001 |
Levels of inflammatory factors in GCF (x̄± s, µg/L)
Control | 45 | 7.65±0.94 | 2.95±0.62 |
15.68±2.74 | 7.16±1.48 |
2.68±0.48 | 1.38±0.41 |
Treatment | 45 | 7.72±1.03 | 2.46±0.43 |
15.73±2.85 | 5.42±1.06 |
2.71±0.53 | 1.05±0.32 |
0.337 | 4.356 | 0.085 | 6.412 | 0.281 | 3.860 | ||
P | 0.737 | <0.001 | 0.933 | <0.001 | 0.779 | <0.001 |
Incidence of adverse reactions [n(%)]
Control | 45 | 2 (4) | 2 (4) | 1 (2) | 5 (10) |
Treatment | 45 | 1 (2) | 0 (0) | 1 (2) | 2 (4) |
χ2 | 1.394 | ||||
P | 0.238 |
Pain degree and MGV (x̄± s)
Control | 45 | 7.31±1.35 | 1.92±0.31 | 0.63±0.12 | 77.65±9.41 | 108.12±10.15 | 136.14±14.27 |
800.00, <0.001 | 1200.00, <0.001 | ||||||
Before vs. 4 weeks after treatment: 26.10, <0.001 | Before vs. 4 weeks after treatment: 15.13, <0.001 | ||||||
Before vs. 8 weeks after treatment: 33.06, <0.001 | Before vs. 8 weeks after treatment: 19.67, <0.001 | ||||||
4 vs. 8 weeks after treatment: 26.03, <0.001 | 4 vs. 8 weeks after treatment: 14.65, <0.001 | ||||||
Treatment | 45 | 7.28±1.27 | 1.06±0.24 | 0.38±0.06 | 78.53±9.52 | 128.04±10.23 | 138.25±15.02 |
1200.00, <0.001 | 1500.00, <0.001 | ||||||
Before vs. 4 weeks after treatment: 32.28, <0.001 | Before vs. 4 weeks after treatment: 24.55, <0.001 | ||||||
Before vs. 8 weeks after treatment: 36.41, <0.001 | Before vs. 8 weeks after treatment: 22.69, <0.001 | ||||||
4 vs. 8 weeks after treatment: 18.44, <0.001 | 4 vs. 8 weeks after treatment: 5.45, <0.001 | ||||||
0.109 | 14.715 | 12.500 | 0.441 | 9.273 | 0.683 | ||
Pbetween groups | 0.914 | <0.001 | <0.001 | 0.660 | <0.001 | 0.496 |
Treatment outcomes [n(%)]
Control | 45 | 25 (55) | 12 (27) | 8 (18) | 37 (82) |
Treatment | 45 | 29 (65) | 15 (33) | 1 (2) | 44 (98) |
χ2 | 6.049 | ||||
P | 0.014 |